Clinical Trial Update: Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial [Phase 2]

View source ↗

Summary

This entry describes the REACH trial, a Phase 2 study of combination therapy approaches for high-risk multiple myeloma, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Mayo Clinic | Conditions: ISS Stage III Plasma Cell Myeloma, Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING